⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CELU News
Celularity Inc. Class A Common Stock
NEXGEL Appoints Ian Blackman as Chief Financial Officer
globenewswire.com
CELU
NXGLW
NXGL
Form 8-K
sec.gov
CELUW
CELU
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
globenewswire.com
CELU
NXGL
Celularity Announces Closing of Transaction with NexGel
globenewswire.com
CELU
CELUW
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
globenewswire.com
CELU
CELUW
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products
globenewswire.com
CELU
NXGL
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities
globenewswire.com
CELU
CELUW
NXGL
Form 8-K
sec.gov
CELU
CELUW
NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products
globenewswire.com
CELU
NXGL
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy
globenewswire.com
CELU
CELUW